MA-BRIGHTCOVE
22.6.2020 05:32:09 CEST | Business Wire | Press release
Brightcove Inc. (NASDAQ: BCOV), the world’s leading video technology platform, announced today that BadaBusiness.com , an ed-tech platform founded by Dr. Vivek Bindra, has set two new Guinness World Records for the largest online business and sales lessons streamed, which were powered by Brightcove. The live webinars were joined by BadaBusiness.com’s customers, as well as attendees looking to ‘learn and earn at home’ by exploring the means of upskilling, training, and acquiring new business knowledge. These webinars are a part of Dr. Vivek Bindra’s ‘India Revival Mission,’ which derived from the impact of COVID-19.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200621005050/en/
The first webinar, titled Largest Online Business Lesson , had a previous record of 12,091 unique attendees, and on April 24, 2020, the stream set a new world record of 18,693 attendees. The second world record was set by BadaBusiness.com on May 31, 2020, when it debuted its Largest Online Sales Lesson webinar with 95,087 attendees. BadaBusiness.com will be hosting the World's Largest Strategy Session on June 27, 2020, to mark International MSME Day .
Brightcove helps organizations in more than 70 countries meet business challenges through its robust, scalable, and intuitive video platform. Powering BadaBusiness.com’s online events is yet another example of how organizations are pushing the boundaries by inspiring, entertaining, and engaging their audiences through video. According to live analytics data captured by Brightcove’s platform, BadaBusiness.com achieved peak traffic of over 2.3 million total video views, over 1.3 million unique viewers, and 345,000 peak concurrent users during the live event on May 31st.
“Our mission is to provide extensive knowledge of practical business strategies and frameworks to enterprises across India so they can grow and strengthen their brand. With video, BadaBusiness.com is able to host online webinars to deliver those important business messages, while also experiencing better engagement with our audiences,” said Dr. Vivek Bindra, Founder of BadaBusiness.com. “Not only is it an accomplishment to simultaneously bring together nearly 100,000 attendees who share similar business goals, but we also broke two Guinness World Records, all thanks to Brightcove’s technology.”
“At Brightcove, we are always working with our customers to pursue unique and innovative use cases of video. BadaBusiness.com’s online events demonstrate how video can offer educational and informative content, while also being one of the best ways to bring people together virtually,” said Charles Chu, Chief Product Officer, Brightcove. “We’re ecstatic that BadaBusiness.com now holds two world records for the largest online streamed events while choosing Brightcove to power those experiences for their audiences.”
About BadaBusiness.com
A technology-enabled training company that provides affordable, available and accessible business training programs to MSME Business Owners, Entrepreneurs and Wantapreneurs in vernacular language, through a combination of online and offline delivery mechanisms. The objective is to empower individual entrepreneurs and small businesses to scale up, by providing them tools and problem-solving support ecosystem.
About Brightcove Inc. (NASDAQ: BCOV)
We are the people behind the world’s leading video technology platform. With our award-winning technology and services, we help organizations in more than 70 countries meet business challenges and create strategic opportunities by inspiring, entertaining, and engaging their audiences through video.
Since Brightcove was established in 2004, we have consistently pushed boundaries to create a platform for people who are serious about video: one that is robust, scalable, and intuitive. Benefiting from a global infrastructure, unrivalled customer support, an extensive partner ecosystem, and relentless investment in R&D, Brightcove video sets the standard for professional grade video management, distribution, and monetization. To learn more, visit www.brightcove.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200621005050/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom